Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.RxElite, a developer and marketer of generic prescription drug products, has terminated its manufacturing and distribution agreement with Minrad International, an interventional pain management business.
Subscribe to our email newsletter
The termination of the manufacturing and distribution agreement allows RxElite to supply anesthetic gas products to its customers from alternative sources.
RxElite said that it will work closely with its customers and vendors to ensure an ongoing supply of the company’s key anesthetic gas products.